Medicare is facing a significant financial strain due to the rising costs of expensive "skin substitutes" made from dried placenta, which have become a costly treatment option. Doctors involved in the prescription process receive attractive discounts from sellers, raising concerns about potential conflicts of interest. This situation underscores broader issues in the healthcare system regarding pricing transparency and the influence of financial incentives on medical decisions, highlighting the need for more rigorous oversight and reform.